Cargando…
Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
A novel potent analog of the branched tail oxyquinoline group of hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors, neuradapt, has been studied in two treatment regimes in an in vitro hypoxia model on murine primary hippocampal cultures. Neuradapt activates the expression of HIF1 and HIF2...
Autores principales: | Savyuk, Maria, Krivonosov, Mikhail, Mishchenko, Tatiana, Gazaryan, Irina, Ivanchenko, Mikhail, Khristichenko, Anna, Poloznikov, Andrey, Hushpulian, Dmitry, Nikulin, Sergey, Tonevitsky, Evgeny, Abuzarova, Guzal, Mitroshina, Elena, Vedunova, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463909/ https://www.ncbi.nlm.nih.gov/pubmed/32722310 http://dx.doi.org/10.3390/antiox9080662 |
Ejemplares similares
-
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
por: Poloznikov, Andrey A., et al.
Publicado: (2021) -
Neuroprotective Effect of Kinase Inhibition in Ischemic Factor Modeling In Vitro
por: Mitroshina, Elena V., et al.
Publicado: (2021) -
Signatures of the Consolidated Response of Astrocytes to Ischemic Factors In Vitro
por: Mitroshina, Elena V., et al.
Publicado: (2020) -
Double-Edged Sword of Vitamin D3 Effects on Primary Neuronal Cultures in Hypoxic States
por: Loginova, Maria, et al.
Publicado: (2021) -
Structure–Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors
por: Poloznikov, Andrey A., et al.
Publicado: (2022)